Plus Plus Analysis/ Europe’s top psychedelic startups to watch, according to investors By Tim Smith in Barcelona Click here to read more
Analysis/ European tech has a mental health problem: here are the startups offering a solution By Kai Nicol-Schwarz Click here to read more
News/ Moka.care raises €15m Series A for its employee mental health platform By Amy Lewin Click here to read more
News/ Alan raises €183m to support Europeans with their mental health By Mimi Billing Click here to read more
Analysis/ Brexit Britain becomes unlikely psychedelic haven as Albert Labs IPOs By Tim Smith in Barcelona Click here to read more
Podcast/ The Sifted Podcast: Magic mushrooms and startup spiritualism By The Sifted Podcast Team Click here to read more
Interview/ Brunch with Sifted: Amanda Feilding and Cosmo Feilding-Mellen on the psychedelic renaissance By Tim Smith in Barcelona Click here to read more
Opinion/ We celebrate unicorns, so why is money still taboo at startups? By James Routledge Click here to read more
Analysis/ Six healthtech startup ideas from top healthtech investors By Connor Bilboe Click here to read more
News/ Psychedelic toad venom could soon be a clinical treatment for depression By Tim Smith in Barcelona Click here to read more
Analysis/ Europe’s 17 healthtech startups to watch, according to top healthtech founders By Connor Bilboe Click here to read more
News/ The Big Idea: can a smartphone game help monitor depression? By Freya Pratty Click here to read more
Companies will continue to invest in tech amidst economic uncertainty. This is why Click here to read more